Results for “Diabetes” 18 results

All 18 Health 15 Economy 2 Society 1
Type 1 Diabetes Drug Delay Puts U.S. Insurers on Defense
Health 24 Jun 2026
Type 1 Diabetes Drug Delay Puts U.S. Insurers on Defense
European immunotherapy approvals for Type 1 diabetes are prompting U.S. insurers to reassess coverage of preventative treatments …
Weekly Insulin Shot Fuels U.S. Push to Simplify Diabetes Care
Health 20 Aug 2026
Weekly Insulin Shot Fuels U.S. Push to Simplify Diabetes Care
New once-weekly jab could ease burden for millions of Americans managing type 2 diabetes.
Young Women's Type 2 Diabetes Surge Strains U.S. Prevention Push
Health 27 Jul 2026
Young Women's Type 2 Diabetes Surge Strains U.S. Prevention Push
CDC funding gaps leave clinics unprepared as diagnosis rates climb in women under 30
Ozempic Muscle Loss Fuels U.S. Drug Pipeline Race
Health 09 Jun 2026
Ozempic Muscle Loss Fuels U.S. Drug Pipeline Race
Ozempic and Wegovy-related muscle loss is spurring a major drug development race, with analysts predicting a $50+ billion market …
Wegovy Pill Form Puts Pressure on U.S. Oral Drug Pipeline
Health 21 Jun 2026
Wegovy Pill Form Puts Pressure on U.S. Oral Drug Pipeline
Novo Nordisk's Wegovy pill formulation submission to the FDA is intensifying competition in the obesity drug market, prompting sc…
Weight-Loss Pill Boom Puts U.S. Insurers on Collision Course
Economy 06 Jul 2026
Weight-Loss Pill Boom Puts U.S. Insurers on Collision Course
Oral GLP-1 drugs enter market as coverage battles intensify across America
Wegovy Pill Form Puts U.S. Oral GLP-1 Market on Notice
Health 12 Jun 2026
Wegovy Pill Form Puts U.S. Oral GLP-1 Market on Notice
Novo Nordisk's Wegovy oral tablet formulation of semaglutide intensifies competition in the U.S. GLP-1 weight-loss drug market, s…
Obesity Surge in Young Adults Strains U.S. Medicaid Budgets
Health 25 Jun 2026
Obesity Surge in Young Adults Strains U.S. Medicaid Budgets
Cost-of-living pressures and ultra-processed foods drive caseload spike
Cardiac Arrest Risk in Heat Puts U.S. Workplace Rules in Focus
Health 26 Jun 2026
Cardiac Arrest Risk in Heat Puts U.S. Workplace Rules in Focus
OSHA faces pressure to expand outdoor heat standards beyond elderly workers
Workplace Walk Breaks Gain Traction in U.S. Corporate Policy
Health 24 Jun 2026
Workplace Walk Breaks Gain Traction in U.S. Corporate Policy
U.S. companies are increasingly implementing workplace walk breaks to combat rising inactivity among American adults, addressing …
Protein Timing in Heat Becomes Key Focus for U.S. Dietitians
Health 10 Jul 2026
Protein Timing in Heat Becomes Key Focus for U.S. Dietitians
Extreme summer temps push American nutrition experts to rethink meal planning advice
Obesity Crisis Hits Hardest Among U.S. Young Adults
Health 05 Jul 2026
Obesity Crisis Hits Hardest Among U.S. Young Adults
New data challenges long-held assumptions about age and weight gain risk
Weight-Loss Jabs Reshape U.S. Consumer Spending Patterns
Economy 08 Jul 2026
Weight-Loss Jabs Reshape U.S. Consumer Spending Patterns
GLP-1 drug surge quietly disrupts retail, food, and beverage sectors
Weight-Loss Drugs Quietly Reshape U.S. Alcohol Industry Math
Society 09 Aug 2026
Weight-Loss Drugs Quietly Reshape U.S. Alcohol Industry Math
GLP-1 adoption surge threatens beer and spirits revenue as habits shift
Measles Surge Abroad Puts U.S. Vaccination Policy Under Scrutiny
Health 09 Jul 2026
Measles Surge Abroad Puts U.S. Vaccination Policy Under Scrutiny
Bangladesh crisis renews CDC debate over domestic immunization gaps
Cyclospora Surge Puts CDC Summer Travel Alerts Under Scrutiny
Health 03 Aug 2026
Cyclospora Surge Puts CDC Summer Travel Alerts Under Scrutiny
Rising parasite cases prompt calls for stronger U.S. traveler health advisories
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Health 14 Aug 2026
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Eli Lilly's oral GLP-1 entry could pressure insurers and rivals as demand surges
MS Drug's U.S. Path Tests Medicare's Coverage Speed
Health 04 Aug 2026
MS Drug's U.S. Path Tests Medicare's Coverage Speed
Fampridine's NHS approval renews pressure on CMS to act on nerve-signal therapies
Topics: NHS Policy Ukraine War NHS Net Zero Starmer Zero League Artificial Intelligence Ukraine Senate Russia Champions Champions League Mental Health Renewable Energy Final Bill Grid Block Target Energy Security Council